248 related articles for article (PubMed ID: 34013802)
1. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
2. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
[TBL] [Abstract][Full Text] [Related]
3. Nomogram Predicting Cause-Specific Mortality in Nonmetastatic Male Breast Cancer: A Competing Risk Analysis.
Sun W; Cheng M; Zhou H; Huang W; Qiu Z
J Cancer; 2019; 10(3):583-593. PubMed ID: 30719155
[No Abstract] [Full Text] [Related]
4. Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
Xu F; Li C; Li X; Huang Q; Han D; Wang H; Zheng S; Lyu J
Clin Breast Cancer; 2021 Dec; 21(6):e704-e714. PubMed ID: 33846097
[TBL] [Abstract][Full Text] [Related]
5. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer.
Lu X; Li X; Ling H; Gong Y; Guo L; He M; Sun H; Hu X
Med Sci Monit; 2020 Sep; 26():e925210. PubMed ID: 32920589
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study.
Pan X; Yang W; Chen Y; Tong L; Li C; Li H
Breast; 2019 Oct; 47():56-61. PubMed ID: 31351202
[TBL] [Abstract][Full Text] [Related]
9. A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis.
Yang R; Wu Y; Qi Y; Liu W; Huang Y; Zhao X; Chen R; He T; Zhong X; Li Q; Zhou L; Chen J
BMC Geriatr; 2023 Sep; 23(1):594. PubMed ID: 37749538
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.
Diao JD; Ma LX; Sun MY; Wu CJ; Wang LJ; Liu YL; Yang YJ
Cancer Med; 2019 Sep; 8(12):5600-5608. PubMed ID: 31407527
[TBL] [Abstract][Full Text] [Related]
11. Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
Zhu J; Zheng H; Ge C; Lin H; Yu K; Wu L; Li D; Zhou S; Tang W; Wang Q; Zhang X; Jin X; Xu X; Du J; Fu J
Clin Breast Cancer; 2022 Apr; 22(3):e296-e309. PubMed ID: 34627728
[TBL] [Abstract][Full Text] [Related]
12. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
[TBL] [Abstract][Full Text] [Related]
13. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
14. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
15. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
[TBL] [Abstract][Full Text] [Related]
16. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
17. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients.
Peng Y; Hu T; Cheng L; Tong F; Cao Y; Liu P; Zhou B; Liu M; Liu H; Guo J; Xie F; Yang H; Wang S; Wang C; Wang S
Front Oncol; 2021; 11():578880. PubMed ID: 33777734
[No Abstract] [Full Text] [Related]
18. Development and Validation of Web-Based Nomograms for Predicting Cause-Specific Mortality in Surgically Resected Nonmetastatic Invasive Breast Cancer: A Population-Based Study.
Chen G; Jia M; Zeng Q; Zhang H
Ann Surg Oncol; 2021 Oct; 28(11):6537-6550. PubMed ID: 34114183
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
20. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
